Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA, seeking the approval of etripamil nasal spray, developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback